Infrarenal Abdominal Aortic Aneurysm Clinical Trial
Official title:
Arterial Stiffness, Blood Pressure and Cardiac Output Study; ABC-study A Prospective, Multidisciplinary Study of Arterial Stiffness Measures in Patients Treated for Aortic Aneurysms in Relation to Blood Pressure and Cardiac Output
Comparison of non-invasively obtained central blood pressure using SphygmoCor and invasively recorded central blood pressure in patients with an AAA that will be treated with EVAR.
Primary objective of the first study: validation of non-invasive central pressure parameters
in patients treated with EVAR against invasive measurements.
Objectives of subsequent studies: Do non-invasive central parameters change over time after
EVAR? What is the influence of intraluminal thrombus (presence, amount, configuration) on
non-invasive central pressure parameters (and other obtained parameters of arterial
stiffness)? Prospective study with consecutive, eligible subject enrollment. All subjects
will undergo the Endovascular Aneurysm repair procedure with an endovascular device. Subjects
will be followed procedurally, at 6-8 weeks and 1 year post implantation.
This study is a collaboration of the following departments of the Vascular Center in the
Rijnstate Hospital Arnhem: Vascular Surgery, Interventional radiology, Internal Vascular
Medicine, Cardiology.
Patients diagnosed with an abdominal aortic or aortoiliac aneurysm who are considered
candidates for endovascular repair and who meet the study eligibility criteria may be
screened for enrollment in the study. Up to 20 subjects will be enrolled .
Pre-procedural high resolution, contrast-enhanced CT scan evaluation to determine anatomical
eligibility for enrollment will be performed within three months of the study procedure,
according to standard care. Following EC/IRB approval of the study and the written informed
consent form, patients will be screened for eligibility. Following informed consent, clinical
characteristics will be reported (from hospital records). Per-procedural PWA measurements
will be performed simultaneously with intravascular pressure measurements pre-implantation
and after completion of the endocasular implantation. Subjects will be followed at 30 days
and 1 year post-implantation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00612924 -
The Vascutek AnacondaTM Stent Graft System Phase II IDE Study
|
N/A |